Development of a Small Hybrid Molecule That Mediates Degradation of His-Tag Fused Proteins.

In recent years, the induction of target-protein degradation via the ubiquitin-proteasome system (UPS) mediated by small molecules has attracted attention, and this approach has applications in pharmaceutical development. However, this technique requires a ligand for the target protein that can be incorporated into tailor-made molecules, and there are many proteins for which such ligands have not been found. In this study, we developed a protein-knockdown method that recognizes a His-tag fused to a protein of interest. This strategy theoretically allows comprehensive targeting of proteins of interest by a particular molecule recognizing the tag. As expected, our hybrid molecule 10 [SNIPER(CH6)] efficiently degraded His-tagged CRABP-II and Smad2 in cells. This system provides an easy method to determine the susceptibility of proteins of interest to UPS-mediated degradation. Furthermore, we hope that this method will become an efficient tool to analyze the function of the UPS.

[1]  Yukihiro Itoh,et al.  G-Protein–Coupled Receptor Kinase 2 as a Potential Modulator of the Hallmarks of Cancer , 2017, Molecular Pharmacology.

[2]  M. Naito,et al.  In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs)* , 2017, The Journal of Biological Chemistry.

[3]  C. Crews,et al.  PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer , 2016, Proceedings of the National Academy of Sciences.

[4]  C. Crews,et al.  Small-Molecule PROTACS: New Approaches to Protein Degradation. , 2016, Angewandte Chemie.

[5]  Eunhwa Ko,et al.  Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL. , 2016, Angewandte Chemie.

[6]  Y. Hashimoto,et al.  Degradation of HaloTag-fused nuclear proteins using bestatin-HaloTag ligand hybrid molecules. , 2015, Organic & biomolecular chemistry.

[7]  I. E. Smith,et al.  Catalytic in vivo protein knockdown by small-molecule PROTACs. , 2015, Nature chemical biology.

[8]  I. E. Smith,et al.  HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins. , 2015, ACS chemical biology.

[9]  James E. Bradner,et al.  Phthalimide conjugation as a strategy for in vivo target protein degradation , 2015, Science.

[10]  C. Crews,et al.  Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. , 2015, Chemistry & biology.

[11]  A. Ciulli,et al.  Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4 , 2015, ACS chemical biology.

[12]  Christopher M. Clouthier,et al.  Coumarin-based fluorogenic probes for no-wash protein labeling. , 2014, Angewandte Chemie.

[13]  M. Naito,et al.  Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin–proteasome pathway , 2014, Cell Death and Disease.

[14]  R. Tampé,et al.  Live-cell targeting of his-tagged proteins by multivalent N-nitrilotriacetic acid carrier complexes. , 2014, Journal of the American Chemical Society.

[15]  E. Lander,et al.  Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.

[16]  M. Naito,et al.  Development of hybrid small molecules that induce degradation of estrogen receptor‐alpha and necrotic cell death in breast cancer cells , 2013, Cancer science.

[17]  J. Doudna,et al.  Molecular mechanisms of RNA interference. , 2013, Annual review of biophysics.

[18]  H. Nonaka,et al.  In-cell covalent labeling of reactive His-tag fused proteins. , 2013, Chemical communications.

[19]  Yukihiro Itoh,et al.  Double protein knockdown of cIAP1 and CRABP-II using a hybrid molecule consisting of ATRA and IAPs antagonist. , 2012, Bioorganic & medicinal chemistry letters.

[20]  M. Naito,et al.  Design and synthesis of estrogen receptor degradation inducer based on a protein knockdown strategy. , 2012, Bioorganic & medicinal chemistry letters.

[21]  Yukihiro Itoh,et al.  Specific degradation of CRABP‐II via cIAP1‐mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein , 2011, FEBS letters.

[22]  Minoru Ishikawa,et al.  Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins. , 2010, Journal of the American Chemical Society.

[23]  Jiangang Gao,et al.  A review of current large‐scale mouse knockout efforts , 2010, Genesis.

[24]  H. Swanson,et al.  Development of an Aryl Hydrocarbon Receptor Antagonist Using the Proteolysis-Targeting Chimeric Molecules Approach: A Potential Tool for Chemoprevention , 2008, Molecular Pharmacology.

[25]  S. Lata,et al.  High-affinity adaptors for switchable recognition of histidine-tagged proteins. , 2005, Journal of the American Chemical Society.

[26]  C. Kos.  Methods in Nutrition Science: Cre/loxP System for Generating Tissue-specific Knockout Mouse Models , 2004 .

[27]  A. Ransick,et al.  Development of Protacs to Target Cancer-promoting Proteins for Ubiquitination and Degradation* , 2003, Molecular & Cellular Proteomics.

[28]  M. Naito,et al.  Molecular Design, Synthesis, and Evaluation of SNIPER(ER) That Induces Proteasomal Degradation of ERα. , 2016, Methods in molecular biology.

[29]  C. Kos.  Special Article: Methods in Nutrition Science Cre/loxP System for Generating Tissue-specific Knockout Mouse Models , 2022 .